Hypotensive drug treatment Brinzolamide CAS 138890-62-7

Basic Info

Model No.: CAS 138890-62-7

Additional Info

Packaging: 1 KG

Transportation: Ocean,Land,Air

Place of Origin: CHINA

Port: QINGDAO

Product Description

[density]: 1.5±0.1 g/cm3
[ Boiling point ]: 586.0±60.0 °C at 760 mmHg
[ Molecular Formula ] : C12H21N3O5S3
[Molecular Weight]: 383.507
[flash point ]: 308.2±32.9 °C
[Exact quality ]: 383.064331
[ PSA ]: 163.80000

[ LogP ]: -0.65

[CAS No.]:138890-62-7

[Refractive index]: 1.626

English alias:

2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (R)-;AL 4862;2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-;Brinzolamide (JAN/USP).

Brinzolamide is a sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II. Following topical ocular administration, brinzolamide inhibits carbonic anhydrase II, an enzyme that is responsible for the movement of sodium and fluid transport in the eye. This inhibition leads to a decrease in aqueous humor secretion, probably by slowing the formation of bicarbonate ions, and results in a reduction in intraocular pressure. Brinzolamide is used to treat increased pressure in the eye caused by open-angle glaucoma.